Figure 3From: Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy A simple bar chart representing the percentages of cases of US detectable forefoot bursal hypertrophy and MTP joint synovial hypertrophy at baseline and following twelve weeks of anti-TNF therapy.Back to article page